Copyright Reports & Markets. All rights reserved.

Global Aluminum-based Vaccine Adjuvant Market Research Report 2021

Request for Sample of this report
Buy now

1 Aluminum-based Vaccine Adjuvant Market Overview

  • 1.1 Product Overview and Scope of Aluminum-based Vaccine Adjuvant
  • 1.2 Aluminum-based Vaccine Adjuvant Segment by Type
    • 1.2.1 Global Aluminum-based Vaccine Adjuvant Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Aluminium Potassium Sulfate Based
    • 1.2.3 Aluminum Phosphate Based
    • 1.2.4 Aluminum Hydroxide Based
  • 1.3 Aluminum-based Vaccine Adjuvant Segment by Application
    • 1.3.1 Aluminum-based Vaccine Adjuvant Sales Comparison by Application: (2021-2027)
    • 1.3.2 Dtap (diphtheria, Tetanus, Acellular Whooping Cough)
    • 1.3.3 Human Papillomavirus
    • 1.3.4 Pneumococcal
    • 1.3.5 Hepatitis A
    • 1.3.6 Hepatitis B
    • 1.3.7 Novel Coronavirus
    • 1.3.8 Other
  • 1.4 Global Aluminum-based Vaccine Adjuvant Market Size Estimates and Forecasts
    • 1.4.1 Global Aluminum-based Vaccine Adjuvant Revenue 2016-2027
    • 1.4.2 Global Aluminum-based Vaccine Adjuvant Sales 2016-2027
    • 1.4.3 Aluminum-based Vaccine Adjuvant Market Size by Region: 2016 Versus 2021 Versus 2027

2 Aluminum-based Vaccine Adjuvant Market Competition by Manufacturers

  • 2.1 Global Aluminum-based Vaccine Adjuvant Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Aluminum-based Vaccine Adjuvant Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Aluminum-based Vaccine Adjuvant Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Aluminum-based Vaccine Adjuvant Manufacturing Sites, Area Served, Product Type
  • 2.5 Aluminum-based Vaccine Adjuvant Market Competitive Situation and Trends
    • 2.5.1 Aluminum-based Vaccine Adjuvant Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Aluminum-based Vaccine Adjuvant Players Market Share by Revenue
    • 2.5.3 Global Aluminum-based Vaccine Adjuvant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Aluminum-based Vaccine Adjuvant Retrospective Market Scenario by Region

  • 3.1 Global Aluminum-based Vaccine Adjuvant Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Aluminum-based Vaccine Adjuvant Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Aluminum-based Vaccine Adjuvant Market Facts & Figures by Country
    • 3.3.1 North America Aluminum-based Vaccine Adjuvant Sales by Country
    • 3.3.2 North America Aluminum-based Vaccine Adjuvant Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Aluminum-based Vaccine Adjuvant Market Facts & Figures by Country
    • 3.4.1 Europe Aluminum-based Vaccine Adjuvant Sales by Country
    • 3.4.2 Europe Aluminum-based Vaccine Adjuvant Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Aluminum-based Vaccine Adjuvant Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Aluminum-based Vaccine Adjuvant Sales by Region
    • 3.5.2 Asia Pacific Aluminum-based Vaccine Adjuvant Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Aluminum-based Vaccine Adjuvant Market Facts & Figures by Country
    • 3.6.1 Latin America Aluminum-based Vaccine Adjuvant Sales by Country
    • 3.6.2 Latin America Aluminum-based Vaccine Adjuvant Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa Aluminum-based Vaccine Adjuvant Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Aluminum-based Vaccine Adjuvant Sales by Country
    • 3.7.2 Middle East and Africa Aluminum-based Vaccine Adjuvant Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Aluminum-based Vaccine Adjuvant Historic Market Analysis by Type

  • 4.1 Global Aluminum-based Vaccine Adjuvant Sales Market Share by Type (2016-2021)
  • 4.2 Global Aluminum-based Vaccine Adjuvant Revenue Market Share by Type (2016-2021)
  • 4.3 Global Aluminum-based Vaccine Adjuvant Price by Type (2016-2021)

5 Global Aluminum-based Vaccine Adjuvant Historic Market Analysis by Application

  • 5.1 Global Aluminum-based Vaccine Adjuvant Sales Market Share by Application (2016-2021)
  • 5.2 Global Aluminum-based Vaccine Adjuvant Revenue Market Share by Application (2016-2021)
  • 5.3 Global Aluminum-based Vaccine Adjuvant Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Emergent BioSolutions
    • 6.1.1 Emergent BioSolutions Corporation Information
    • 6.1.2 Emergent BioSolutions Description and Business Overview
    • 6.1.3 Emergent BioSolutions Aluminum-based Vaccine Adjuvant Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Emergent BioSolutions Product Portfolio
    • 6.1.5 Emergent BioSolutions Recent Developments/Updates
  • 6.2 Sanofi
    • 6.2.1 Sanofi Corporation Information
    • 6.2.2 Sanofi Description and Business Overview
    • 6.2.3 Sanofi Aluminum-based Vaccine Adjuvant Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Sanofi Product Portfolio
    • 6.2.5 Sanofi Recent Developments/Updates
  • 6.3 GlaxoSmithKline Biologicals
    • 6.3.1 GlaxoSmithKline Biologicals Corporation Information
    • 6.3.2 GlaxoSmithKline Biologicals Description and Business Overview
    • 6.3.3 GlaxoSmithKline Biologicals Aluminum-based Vaccine Adjuvant Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 GlaxoSmithKline Biologicals Product Portfolio
    • 6.3.5 GlaxoSmithKline Biologicals Recent Developments/Updates
  • 6.4 Pfizer
    • 6.4.1 Pfizer Corporation Information
    • 6.4.2 Pfizer Description and Business Overview
    • 6.4.3 Pfizer Aluminum-based Vaccine Adjuvant Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Pfizer Product Portfolio
    • 6.4.5 Pfizer Recent Developments/Updates
  • 6.5 Merck
    • 6.5.1 Merck Corporation Information
    • 6.5.2 Merck Description and Business Overview
    • 6.5.3 Merck Aluminum-based Vaccine Adjuvant Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Merck Product Portfolio
    • 6.5.5 Merck Recent Developments/Updates
  • 6.6 Wyeth Pharmaceuticals
    • 6.6.1 Wyeth Pharmaceuticals Corporation Information
    • 6.6.2 Wyeth Pharmaceuticals Description and Business Overview
    • 6.6.3 Wyeth Pharmaceuticals Aluminum-based Vaccine Adjuvant Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Wyeth Pharmaceuticals Product Portfolio
    • 6.6.5 Wyeth Pharmaceuticals Recent Developments/Updates

7 Aluminum-based Vaccine Adjuvant Manufacturing Cost Analysis

  • 7.1 Aluminum-based Vaccine Adjuvant Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Aluminum-based Vaccine Adjuvant
  • 7.4 Aluminum-based Vaccine Adjuvant Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Aluminum-based Vaccine Adjuvant Distributors List
  • 8.3 Aluminum-based Vaccine Adjuvant Customers

9 Aluminum-based Vaccine Adjuvant Market Dynamics

  • 9.1 Aluminum-based Vaccine Adjuvant Industry Trends
  • 9.2 Aluminum-based Vaccine Adjuvant Growth Drivers
  • 9.3 Aluminum-based Vaccine Adjuvant Market Challenges
  • 9.4 Aluminum-based Vaccine Adjuvant Market Restraints

10 Global Market Forecast

  • 10.1 Aluminum-based Vaccine Adjuvant Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Aluminum-based Vaccine Adjuvant by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Aluminum-based Vaccine Adjuvant by Type (2022-2027)
  • 10.2 Aluminum-based Vaccine Adjuvant Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Aluminum-based Vaccine Adjuvant by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Aluminum-based Vaccine Adjuvant by Application (2022-2027)
  • 10.3 Aluminum-based Vaccine Adjuvant Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Aluminum-based Vaccine Adjuvant by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Aluminum-based Vaccine Adjuvant by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Aluminium Potassium Sulfate Based
    Aluminum Phosphate Based
    Aluminum Hydroxide Based

    Segment by Application
    Dtap (diphtheria, Tetanus, Acellular Whooping Cough)
    Human Papillomavirus
    Pneumococcal
    Hepatitis A
    Hepatitis B
    Novel Coronavirus
    Other

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Emergent BioSolutions
    Sanofi
    GlaxoSmithKline Biologicals
    Pfizer
    Merck
    Wyeth Pharmaceuticals

    Buy now